Abstract PS1-03: Active surveillance for DCIS: Clinical outcomes at 5.6 years mean follow-upCase Brabham, Laura J. Esserman, Gillian L. Hirst et al.|Cancer Research|2021Cited by 0
Abstract PD9-04: Identification of biomarkers associated with therapeutic resistance: Quantitative protein/phosphoprotein analysis of ~750 patients across 8 arms of the neoadjuvant I-SPY 2 TRIAL for high-risk early stage breast cancerJulia Wulfkuhle, Emanual Petricoin, Denise Wolf et al.|Cancer Research|2021Cited by 0